Charles Schwab Investment Management Inc. Has $42.16 Million Position in Exponent, Inc. $EXPO

Charles Schwab Investment Management Inc. cut its stake in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 1.0% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 520,131 shares of the business services provider's stock after selling 5,247 shares during the quarter. Charles Schwab Investment Management Inc. owned about 1.02% of Exponent worth $42,162,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the business. Whipplewood Advisors LLC grew its stake in shares of Exponent by 5,333.3% during the 1st quarter. Whipplewood Advisors LLC now owns 326 shares of the business services provider's stock worth $26,000 after purchasing an additional 320 shares during the period. UMB Bank n.a. lifted its stake in shares of Exponent by 859.1% in the 1st quarter. UMB Bank n.a. now owns 633 shares of the business services provider's stock valued at $51,000 after purchasing an additional 567 shares in the last quarter. Bessemer Group Inc. raised its holdings in Exponent by 103.3% in the first quarter. Bessemer Group Inc. now owns 681 shares of the business services provider's stock valued at $55,000 after buying an additional 346 shares during the period. Johnson Financial Group Inc. purchased a new position in shares of Exponent during the 4th quarter valued at approximately $59,000. Finally, LRI Investments LLC boosted its stake in Exponent by 30.4% during the 4th quarter. LRI Investments LLC now owns 1,460 shares of the business services provider's stock valued at $130,000 after acquiring an additional 340 shares during the last quarter. Institutional investors and hedge funds own 92.37% of the company's stock.

Exponent Trading Up 0.5%

Exponent stock traded up $0.3250 during midday trading on Thursday, hitting $70.3550. The stock had a trading volume of 347,748 shares, compared to its average volume of 320,600. The business has a fifty day moving average price of $73.01 and a 200 day moving average price of $78.36. Exponent, Inc. has a 12 month low of $63.81 and a 12 month high of $115.75. The stock has a market cap of $3.55 billion, a P/E ratio of 35.17 and a beta of 0.89.

Exponent (NASDAQ:EXPO - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The business services provider reported $0.52 EPS for the quarter, topping analysts' consensus estimates of $0.48 by $0.04. Exponent had a return on equity of 24.19% and a net margin of 18.35%.The firm had revenue of $132.87 million during the quarter, compared to the consensus estimate of $130.82 million. During the same period in the prior year, the business earned $0.57 EPS. The firm's revenue was up 7.3% on a year-over-year basis. On average, equities analysts anticipate that Exponent, Inc. will post 1.98 EPS for the current fiscal year.

Exponent Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, September 19th. Stockholders of record on Friday, September 5th will be issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.7%. The ex-dividend date is Friday, September 5th. Exponent's payout ratio is currently 60.00%.

Insider Transactions at Exponent

In related news, VP Joseph Rakow sold 1,573 shares of Exponent stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $77.72, for a total value of $122,253.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, VP John Pye sold 2,000 shares of the company's stock in a transaction on Friday, May 23rd. The shares were sold at an average price of $76.32, for a total transaction of $152,640.00. Following the completion of the sale, the vice president owned 29,204 shares of the company's stock, valued at approximately $2,228,849.28. This represents a 6.41% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 10,064 shares of company stock worth $735,621. 1.60% of the stock is owned by corporate insiders.

About Exponent

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.